CIM
Contravisory Investment Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $663K | Sell |
6,169
-82
| -1% | -$8.81K | 0.13% | 108 |
|
|
2025
Q1 | $631K | Sell |
6,251
-538
| -8% | -$54.3K | 0.13% | 106 |
|
|
2024
Q4 | $606K | Sell |
6,789
-684
| -9% | -$61.1K | 0.13% | 106 |
|
|
2024
Q3 | $626K | Buy |
7,473
+323
| +5% | +$27.1K | 0.13% | 105 |
|
|
2024
Q2 | $551K | Sell |
7,150
-295
| -4% | -$22.7K | 0.12% | 109 |
|
|
2024
Q1 | $510K | Buy |
7,445
+10
| +0.1% | +$685 | 0.11% | 119 |
|
|
2023
Q4 | $430K | Buy |
7,435
+35
| +0.5% | +$2.02K | 0.11% | 142 |
|
|
2023
Q3 | $391K | Sell |
7,400
-390
| -5% | -$20.6K | 0.11% | 133 |
|
|
2023
Q2 | $421K | Buy |
+7,790
| New | +$421K | 0.11% | 133 |
|
|
2020
Q2 | – | Sell |
-1,989
| Closed | -$65K | – | 262 |
|
|
2020
Q1 | $65K | Buy |
1,989
+193
| +11% | +$6.31K | 0.03% | 203 |
|
|
2019
Q4 | $81K | Buy |
1,796
+262
| +17% | +$11.8K | 0.03% | 203 |
|
|
2019
Q3 | $62K | Buy |
+1,534
| New | +$62K | 0.02% | 213 |
|
|
2017
Q4 | – | Sell |
-22
| Closed | -$1K | – | 445 |
|
|
2017
Q3 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 397 |
|
|
2015
Q1 | – | Sell |
-1,680
| Closed | -$22K | – | 167 |
|
|
2014
Q4 | $22K | Sell |
1,680
-815,552
| -100% | -$10.7M | ﹤0.01% | 102 |
|
|
2014
Q3 | $9.65M | Sell |
817,232
-50,476
| -6% | -$596K | 2.01% | 35 |
|
|
2014
Q2 | $11.1M | Sell |
867,708
-36,118
| -4% | -$461K | 2.19% | 31 |
|
|
2014
Q1 | $12.2M | Buy |
+903,826
| New | +$12.2M | 2.4% | 24 |
|